Biotech Valuation

When I was a young lawyer in 1997 at Cyrano Sciences, a company founded by Caltech Professors Nathan S. Lewis and Nobel Laureate Robert H. Grubbs, someone was kind enough to show me the basic metrics of valuing a drug opportunity.  Nothing fancy.